This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2lkj
From Proteopedia
| Line 1: | Line 1: | ||
| - | [[Image:2lkj.png|left|200px]] | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_2lkj", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_2lkj| PDB=2lkj | SCENE= }} | {{STRUCTURE_2lkj| PDB=2lkj | SCENE= }} | ||
| - | |||
===Structures and Interaction Analyses of the Integrin Alpha-M Beta-2 Cytoplasmic Tails=== | ===Structures and Interaction Analyses of the Integrin Alpha-M Beta-2 Cytoplasmic Tails=== | ||
| + | {{ABSTRACT_PUBMED_22052909}} | ||
| + | ==Disease== | ||
| + | [[http://www.uniprot.org/uniprot/ITAM_HUMAN ITAM_HUMAN]] Genetic variations in ITGAM has been associated with susceptibility to systemic lupus erythematosus type 6 (SLEB6) [MIM:[http://omim.org/entry/609939 609939]]. Systemic lupus erythematosus (SLE) is a chronic, inflammatory and often febrile multisystemic disorder of connective tissue. It affects principally the skin, joints, kidneys and serosal membranes. It is thought to represent a failure of the regulatory mechanisms of the autoimmune system. | ||
| - | + | ==Function== | |
| - | + | [[http://www.uniprot.org/uniprot/ITAM_HUMAN ITAM_HUMAN]] Integrin alpha-M/beta-2 is implicated in various adhesive interactions of monocytes, macrophages and granulocytes as well as in mediating the uptake of complement-coated particles. It is identical with CR-3, the receptor for the iC3b fragment of the third complement component. It probably recognizes the R-G-D peptide in C3b. Integrin alpha-M/beta-2 is also a receptor for fibrinogen, factor X and ICAM1. It recognizes P1 and P2 peptides of fibrinogen gamma chain. | |
| - | + | ||
| - | -- | + | |
| - | + | ||
==About this Structure== | ==About this Structure== | ||
| Line 22: | Line 13: | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:022052909</ref><references group="xtra"/> | + | <ref group="xtra">PMID:022052909</ref><references group="xtra"/><references/> |
[[Category: Amalraj, M.]] | [[Category: Amalraj, M.]] | ||
[[Category: Bhattacharjya, S.]] | [[Category: Bhattacharjya, S.]] | ||
Revision as of 23:35, 24 March 2013
Contents |
Structures and Interaction Analyses of the Integrin Alpha-M Beta-2 Cytoplasmic Tails
Template:ABSTRACT PUBMED 22052909
Disease
[ITAM_HUMAN] Genetic variations in ITGAM has been associated with susceptibility to systemic lupus erythematosus type 6 (SLEB6) [MIM:609939]. Systemic lupus erythematosus (SLE) is a chronic, inflammatory and often febrile multisystemic disorder of connective tissue. It affects principally the skin, joints, kidneys and serosal membranes. It is thought to represent a failure of the regulatory mechanisms of the autoimmune system.
Function
[ITAM_HUMAN] Integrin alpha-M/beta-2 is implicated in various adhesive interactions of monocytes, macrophages and granulocytes as well as in mediating the uptake of complement-coated particles. It is identical with CR-3, the receptor for the iC3b fragment of the third complement component. It probably recognizes the R-G-D peptide in C3b. Integrin alpha-M/beta-2 is also a receptor for fibrinogen, factor X and ICAM1. It recognizes P1 and P2 peptides of fibrinogen gamma chain.
About this Structure
2lkj is a 1 chain structure. Full experimental information is available from OCA.
Reference
- Chua GL, Tang XY, Amalraj M, Tan SM, Bhattacharjya S. Structures and interaction analyses of the integrin alphaMbeta2 cytoplasmic tails. J Biol Chem. 2011 Nov 3. PMID:22052909 doi:10.1074/jbc.M111.280164
